estudio flow semaglutide in CKD? Check out the trial #VisualAbstract #nephrology #medtwitter Novo Nordisk's therapy lowers kidney
Description
Tirzepatide (both injection and oral forms available) targets an additional receptor pathway (GIP) beyond the GLP-1 pathway, which increases potency but also slightly raises the likelihood of nausea in early weeks
This appetite suppression can feel quite profound and sometimes unexpected in its intensity
The medication works similarly to the hormone, curbing appetite and, therefore, prompting weight loss
Colagiuri S, Frid A, Zdravkovic M, Le-Thi T, Vaag A
persistent or permanent AF is the most prevalent type in diabetic populations, according to a recent meta-analysis of 20 relevant studies [7]
